{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ORINY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORINY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORINY\",,,,,undefined,":{"symbol":"ORINY","market":"US","secType":"STK","nameCN":"Orion Corporation OY","latestPrice":36.45,"timestamp":1749755925832,"preClose":36.45,"halted":0,"volume":26,"delay":15,"floatShares":243189192,"shares":281002846,"eps":0.830675,"marketStatus":"Pre-Mkt","change":0,"latestTime":"06-12 15:18:45 EDT Delay","open":36.45,"high":36.45,"low":36.45,"amount":968.26,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.830675,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749821400000},"marketStatusCode":1,"adr":0,"adrRate":0.5,"exchange":"PINK LIMITED","adjPreClose":36.45,"volumeRatio":0.18131116985593015},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORINY\",,,,,undefined,":{"symbol":"ORINY","floatShares":243189192,"roa":"15.58%","roe":"39.16%","lyrEps":0.853855,"volumeRatio":0.18131116985593015,"shares":281002846,"dividePrice":0.9,"high":36.45,"amplitude":0,"preClose":36.45,"low":36.45,"week52Low":21.1,"pbRate":"8.35","psRate":"5.61","week52High":36.45,"institutionHeld":0,"latestPrice":36.45,"eps":0.830675,"divideRate":0.024691,"volume":26,"delay":15,"ttmEps":0.830675,"open":36.45,"prevYearClose":21.95,"prevWeekClose":35.72,"prevMonthClose":33.52,"prevQuarterClose":29.97,"fiveDayClose":35.72,"twentyDayClose":30.27,"sixtyDayClose":29.76},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ORINY\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ORINY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533268538","title":"Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533268538","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533268538?lang=en_us&edition=fundamental","pubTime":"2025-05-05 22:00","pubTimestamp":1746453600,"startTime":"0","endTime":"0","summary":"ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS5 May 2025 at 17:00EEST. Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 2 May 2025 above five  per cent of Orion Corporation’s total shares.Total positions of BlackRock, Inc. and its funds subject to notification:. % of shares and voting rights through financial instruments . Total number of shares and voting rights of issuer. Resulting situation on the date on which threshold was crossed or reached. Notified details of the resulting situation on the date on which the threshold was crossed:. Point B: Financial instruments according to SMA 9:6a:. Contact person:Tuukka Hirvonen, Investor Relations, Orion Corporationtel. +358 10426 2721. Orion is a globally operating Finnish pharmaceutical company – a build","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/orion-corporation-disclosure-under-chapter-140000281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BVYPNV92.GBP","LU0772969993.USD","LU0742537680.HKD","IE00BGHQF748.EUR","LU1989771016.USD","LU0980610538.SGD","LU0731783048.USD","IE00B42XCP33.USD","LU2505996509.AUD","LU2430703251.USD","LU2264538146.SGD","IE00B64PRP62.GBP","LU1280957306.USD","LU1599440770.SGD","BK4534","LU0731783394.SGD","BK4007","BK4535","IE00B3PB1722.GBP","IE00BVYPNW00.USD","BK4588","IE00B3QW5Z07.USD","BK4135","LU1481011671.HKD","ORINF","LU2430703178.SGD","IE00BGHQF631.EUR","LU0070302665.USD","LU0648001328.SGD","BLK","LU1064131342.USD","BK4567","LU0208291251.USD","LU0130102774.USD","LU1481011911.USD","IE00BDGV0183.EUR","LU1670627923.USD","LU2592432038.USD","LU1509826696.USD","BK4581","LU1670628061.USD","BK4533","LU1201861249.SGD","LU1291159041.SGD","LU2430703095.HKD","LU2505996681.GBP","ORINY","LU0640476718.USD","LU0320765489.SGD","BK4504","LU1988902786.USD"],"gpt_icon":0},{"id":"2532479843","title":"Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)","url":"https://stock-news.laohu8.com/highlight/detail?id=2532479843","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532479843?lang=en_us&edition=fundamental","pubTime":"2025-05-02 20:15","pubTimestamp":1746188100,"startTime":"0","endTime":"0","summary":"ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS2 May 2025 at 15.15 EEST. Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds decreased on 1 May 2025 below five  per cent of Orion Corporation’s total shares.Total positions of BlackRock, Inc. and its funds subject to notification:. % of shares and voting rights through financial instruments . Total number of shares and voting rights of issuer. Resulting situation on the date on which threshold was crossed or reached. Notified details of the resulting situation on the date on which the threshold was crossed:. Contact person:Tuukka Hirvonen, Investor Relations, Orion Corporationtel. +358 10426 2721. Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/orion-corporation-disclosure-under-chapter-121500832.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1064131342.USD","LU1481011671.HKD","LU0070302665.USD","BK4588","LU1201861249.SGD","LU1599440770.SGD","LU2430703178.SGD","BK4534","IE00BGHQF748.EUR","BLK","BK4585","LU0731783048.USD","IE00BGHQF631.EUR","IE00B42XCP33.USD","BK4567","LU0742537680.HKD","LU0980610538.SGD","BK4007","LU1481011911.USD","LU2264538146.SGD","LU2505996509.AUD","LU2505996681.GBP","LU0731783394.SGD","BK4217","LU0320765489.SGD","LU2592432038.USD","BK4535","IE00BDGV0183.EUR","LU1291159041.SGD","LU0640476718.USD","LU1670627923.USD","IE00BVYPNV92.GBP","LU1280957306.USD","LU0648001328.SGD","IE00B3PB1722.GBP","LU0772969993.USD","ORINY","LU2430703251.USD","LU0208291251.USD","BK4504","SMA","BK4533","LU1509826696.USD","LU0130102774.USD","IE00B64PRP62.GBP","LU1989771016.USD","BK4581","LU2430703095.HKD","IE00B3QW5Z07.USD","ORINF","BK4135"],"gpt_icon":0},{"id":"2532681350","title":"Orion Corporation: Managers’ transactions – Karen Lykke Sørensen","url":"https://stock-news.laohu8.com/highlight/detail?id=2532681350","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532681350?lang=en_us&edition=fundamental","pubTime":"2025-05-02 16:45","pubTimestamp":1746175500,"startTime":"0","endTime":"0","summary":"ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST. Orion Corporation has received the following disclosure under Market Abuse Regulation  No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Transaction details: Volume: 415 Unit price: 0 EUR. Orion is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. In 2024 Orion's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/orion-corporation-managers-transactions-karen-084500137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4156","BK4007","ORINF","EU","ORINY"],"gpt_icon":1},{"id":"2532181368","title":"Orion Corporation: Managers’ transactions – Ari Lehtoranta","url":"https://stock-news.laohu8.com/highlight/detail?id=2532181368","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532181368?lang=en_us&edition=fundamental","pubTime":"2025-05-02 16:45","pubTimestamp":1746175500,"startTime":"0","endTime":"0","summary":"ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST. Orion Corporation has received the following disclosure under Market Abuse Regulation  No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Transaction details: Volume: 508 Unit price: 0 EUR. Orion is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. In 2024 Orion's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/orion-corporation-managers-transactions-ari-084500469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ORINF","BK4007","EU","BK4156","ORINY"],"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORINY\",params:#limit:5,,,undefined,":[{"date":"2025-04-07","symbol":"ORINY","amount":0.447761,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-07","defaultRemindTime":1744032600000,"name":"Orion Corporation OY","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-29","payableDate":"2025-04-07","currency":"USD","dateTimestamp":1743998400000,"payDate":"2025-04-29"},{"date":"2024-10-16","symbol":"ORINY","amount":0.446953,"announcedDate":"2024-10-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-10-16","defaultRemindTime":1729085400000,"name":"Orion Corporation OY","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-07","payableDate":"2024-10-16","currency":"USD","dateTimestamp":1729051200000,"payDate":"2024-11-07"},{"market":"US","date":"2024-04-25","symbol":"ORINY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"pre","actualEps":null},{"date":"2024-03-21","symbol":"ORINY","amount":0.1084079,"announcedDate":"2024-02-27","type":"dividend","market":"US","newRecordDate":"2024-03-22","defaultRemindTime":1711027800000,"name":"Orion Corporation OY","recordDate":null,"payableDate":"2024-03-22","currency":"USD","dateTimestamp":1710993600000,"payDate":null},{"market":"US","date":"2023-03-23","symbol":"ORINY","amount":0.85388,"defaultRemindTime":1679578200000,"name":"Orion Corporation OY","recordDate":"2023-04-17","payableDate":"2023-03-24","currency":"USD","type":"dividend","dateTimestamp":1679544000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORINY\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-22","recordDate":"2016-03-24","paymentDate":"2016-04-14","value":0.467153,"currency":"USD"},{"executeDate":"2019-03-27","recordDate":"2019-03-28","paymentDate":"2019-04-19","value":0.668881,"currency":"USD"},{"executeDate":"2020-03-26","recordDate":"2020-03-27","paymentDate":"2020-04-20","value":0.366737,"currency":"USD"},{"executeDate":"2020-05-07","recordDate":"2020-05-08","paymentDate":"2020-06-01","value":0.52036,"currency":"USD"},{"executeDate":"2021-03-26","recordDate":"2021-03-29","paymentDate":"2021-04-22","value":0.540167,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORINY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.2857,"hold":0.1429,"sell":0.2857,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1745553600000}}}